(Q39364492)

11 September 2017

Differential effects of AKT1(p.E17K) expression on human mammary luminal epithelial and myoepithelial cells (English)

1 reference

11 September 2017

Bodour Salhia

1

1 reference

11 September 2017

Courtney Van Cott

2

1 reference

11 September 2017

Tony Tegeler

3

1 reference

11 September 2017

Ashoka Polpitiya

4

1 reference

11 September 2017

Rachelle A Duquette

5

1 reference

11 September 2017

Molly Gale

6

1 reference

11 September 2017

Galen Hostteter

7

1 reference

11 September 2017

Konstantinos Petritis

8

1 reference

11 September 2017

John Carpten

9

1 reference

11 September 2017

language of work or name

1 reference

11 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

33

1 reference

11 September 2017

1216-1227

1 reference

11 September 2017

8

1 reference

FoxOs at the crossroads of cellular metabolism, differentiation, and transformation

11 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

A portrait of AKT kinases: human cancer and animal models depict a family with strong individualities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

The Akt activation inhibitor TCN-P inhibits Akt phosphorylation by binding to the PH domain of Akt and blocking its recruitment to the plasma membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

AKT1(E17K) in human solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Absence of AKT1 mutations in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Absence of E17K mutation in the pleckstrin homology domain of AKT1 in gastrointestinal and liver cancers in the Korean population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

The DEAD-box protein family of RNA helicases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Detection of the transforming AKT1 mutation E17K in non-small cell lung cancer by high resolution melting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Phosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

PI3K/Akt signalling pathway and cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

AKT involvement in cisplatin chemoresistance of human uterine cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Exploring the specificity of the PI3K family inhibitor LY294002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

New model of ErbB-2 over-expression in human mammary luminal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Post-transcriptional nucleotide modification and alternative folding of RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

c-Jun supports ribosomal RNA processing and nucleolar localization of RNA helicase DDX21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Akt1 governs breast cancer progression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

AKT activation predicts outcome in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Global phosphoproteomics identifies a major role for AKT and 14-3-3 in regulating EDC3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

A mosaic activating mutation in AKT1 associated with the Proteus syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

AKT/PKB signaling: navigating downstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

AKT1 (E17K) mutation in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

The protein kinase B/Akt signalling pathway in human malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

PI3K-Akt pathway: its functions and alterations in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

The GRP1 PH domain, like the AKT1 PH domain, possesses a sentry glutamate residue essential for specific targeting to plasma membrane PI(3,4,5)P(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

DAnTE: a statistical tool for quantitative analysis of -omics data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

The guanine nucleotide exchange factors trio, Ect2, and Vav3 mediate the invasive behavior of glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

TOR, a central controller of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Involvement of the Akt/PKB signaling pathway with disease processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

AKT plays a central role in tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Tandem Mass Tags: A Novel Quantification Strategy for Comparative Analysis of Complex Protein Mixtures by MS/MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

High prevalence of PIK3CA/AKT pathway mutations in papillary neoplasms of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

AKT signaling in physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Sulforhodamine B colorimetric assay for cytotoxicity screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

7 January 2021

Genetic alterations in 'normal' luminal and myoepithelial cells of the breast

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

7 January 2021

Akt1 inhibition by RNA interference sensitizes human non-small cell lung cancer cells to cisplatin

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

7 January 2021

Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.22100

7 January 2021

Identifiers

DOI

10.1002/HUMU.22100

1 reference

11 September 2017

1 reference